Agranulocytosis

	Agranulocytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Agranulocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Agranulocytosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Agranulocytosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Agranulocytosis
CDC on Agranulocytosis
Agranulocytosis in the news
Blogs on Agranulocytosis</small>
Directions to Hospitals Treating Agranulocytosis
Risk calculators and risk factors for Agranulocytosis

	Agranulocytosis;
	Bone marrow smear from a patient with drug-related agranulocytosis. There are numerous promyelocytes and myelocytes with essentially no evidence of maturation to segmented neutrophils. (Wright-Giemsa stain) ; Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10	D70.
ICD-9	288.0

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview


Agranulocytosis
Bone marrow smear from a patient with drug-related agranulocytosis. There are numerous promyelocytes and myelocytes with essentially no evidence of maturation to segmented neutrophils. (Wright-Giemsa stain) Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10	D 70.
ICD-9	288.0